Marc Dechamps

Director/Board Member at OSE IMMUNOTHERAPEUTICS

Health Technology

Profile

Marc Dechamps is currently an Independent Director at OSE Immunotherapeutics SA. Previously, he worked as the Co-Managing Director at Delphi Genetics SA and as the Director & Head of Business Development at eTheRNA immunotherapies NV.

Marc Dechamps active positions

Companies	Position	Start
OSE IMMUNOTHERAPEUTICS	Director/Board Member	18/06/2024

All active positions of Marc Dechamps

Former positions of Marc Dechamps

Companies	Position	End
Delphi Genetics SA Delphi Genetics SA BiotechnologyHealth Technology Delphi Genetics SA develops products and technologies for gene cloning and protein expression in bacteria. It offers deoxyribonucleic acid (DNA), antibody development, molecular biology, protein purification, vector adaption, and DNA immunization services. The company was founded by Philippe Gabant, Michel Milinkovitch, and Cedric Szpirer in 2001 and is headquartered in Charleroi, Belgium.	Chief Executive Officer	30/06/2017
eTheRNA immunotherapies NV eTheRNA immunotherapies NV BiotechnologyHealth Technology eTheRNA immunotherapies NV develops novel immunotherapies to overcome cancers and infectious diseases. The company was founded by Carlo Heirman, Kris Thielemans and Sonja van Meirvenne in January 21, 2013 and is headquartered in Niel, Belgium.	Director/Board Member	-

See the detail of Marc Dechamps's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Marc Dechamps's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	1
OSE IMMUNOTHERAPEUTICS	Health Technology

Private companies	2
Delphi Genetics SA Delphi Genetics SA BiotechnologyHealth Technology Delphi Genetics SA develops products and technologies for gene cloning and protein expression in bacteria. It offers deoxyribonucleic acid (DNA), antibody development, molecular biology, protein purification, vector adaption, and DNA immunization services. The company was founded by Philippe Gabant, Michel Milinkovitch, and Cedric Szpirer in 2001 and is headquartered in Charleroi, Belgium.	Health Technology
eTheRNA immunotherapies NV eTheRNA immunotherapies NV BiotechnologyHealth Technology eTheRNA immunotherapies NV develops novel immunotherapies to overcome cancers and infectious diseases. The company was founded by Carlo Heirman, Kris Thielemans and Sonja van Meirvenne in January 21, 2013 and is headquartered in Niel, Belgium.	Health Technology